Apple Inc. vs Bio-Rad Laboratories, Inc.Class A
AAPL vs BIO — side-by-side comparison from reported financials. AAPL leads 9, BIO leads 2 of 11 comparable metrics.
Apple Inc.
AAPL · Technology
$336.11-1.27%Strong
Bio-Rad Laboratories, Inc.Class A
BIO · Technology
$366.16+1.60%Strong
| Metric | AAPL | BIO |
|---|---|---|
| Price | $336.11 | $366.16 |
| Market cap | $4.91T | $9.79B |
| Revenue (TTM) | $467B | $2.59B |
| Revenue growth | +1.8% | -2.7% |
| Net margin | 27.6% | 8.6% |
| Free cash flow | $137B | $353M |
| Net cash (debt) | ($31.6B) | $339M |
| 1-year price return | +32.3% | +21.8% |
| P/E | 38.1 | 44.3 |
| P/E vs own history (cheap-side %) | 7% | 26% |
| Dividend yield | 0.32% | — |
| Return on equity | 137% | 3% |
| Altman Z-score | 12.84 | 3.41 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 166,000 | 7,450 |
Full résumé-style profiles: AAPL CV · BIO CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.